Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis
NCT07228104Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- May 2026
- Primary completion
- Jan 2031
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone in idiopathic subglottic stenosis (ISS), sponsored by Johns Hopkins University. Started May 2026; status: recruiting.
02
Drugs
triamcinolone
03
Conditions
idiopathic subglottic stenosis (ISS)
Beyond the preview
Go deeper on NCT07228104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07228104.